speb/financial-data huggingface dataset:
PAMT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -20673000.00
PAMT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 28653000.00
PAMT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -2689000.00
PAMT cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 8058000.00
PAMT cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 1200000.00
PAMT cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 89000.00
PAMT cash_flow (quarterly, 2026-03-31) — Change In Payable: 8147000.00
PAMT cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 9347000.00
PAMT cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 984000.00
PAMT cash_flow (quarterly, 2026-03-31) — Change In Receivables: -13637000.00
PAMT cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 89000.00
PAMT cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -3306000.00
PAMT cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -13637000.00
PAMT cash_flow (quarterly, 2026-03-31) — Changes In Cash: 5291000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Common Stock: 224000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 210426000.00
PAMT cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -11000.00
PAMT income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 145476000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 42424000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Current Assets: 180991000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Current Debt: 68675000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 68675000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 139080000.00
PAMT cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -2000.00
PAMT cash_flow (quarterly, 2026-03-31) — Deferred Tax: -2000.00
PAMT cash_flow (quarterly, 2026-03-31) — Depreciation: 19244000.00
PAMT cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 19244000.00
PAMT cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 19244000.00
PAMT income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 20943237.00
PAMT income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.00
PAMT income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -8000.00
PAMT income_statement (quarterly, 2026-03-31) — EBIT: 4526000.00
PAMT income_statement (quarterly, 2026-03-31) — EBITDA: 23770000.00
PAMT cash_flow (quarterly, 2026-03-31) — End Cash Position: 40525000.00
PAMT cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -20673000.00
PAMT cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -17088000.00
PAMT cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -3931000.00
PAMT cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -15146000.00
PAMT income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 15146000.00
PAMT income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 5208000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 86525000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Gross PPE: 759996000.00
PAMT income_statement (quarterly, 2026-03-31) — Gross Profit: -3596000.00
PAMT income_statement (quarterly, 2026-03-31) — Insurance And Claims: 5208000.00
PAMT income_statement (quarterly, 2026-03-31) — Interest Expense: 4536000.00
PAMT income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 4536000.00
PAMT cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 4002000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Inventory: 2561000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Invested Capital: 531077000.00
PAMT cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 28653000.00
PAMT cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 144983000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 26176000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 251976000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 251976000.00
PAMT cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -20662000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 16724000.00
PAMT cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
PAMT cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -11000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Net Debt: 280126000.00
PAMT income_statement (quarterly, 2026-03-31) — Net Income: -8000.00
PAMT income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -8000.00
PAMT income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -8000.00
PAMT income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -8000.00
PAMT income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -8000.00
PAMT cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -8000.00
PAMT income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -8000.00
PAMT income_statement (quarterly, 2026-03-31) — Net Interest Income: -4536000.00
PAMT cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 11663000.00
PAMT cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -20662000.00
PAMT cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -20662000.00
PAMT income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -4536000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Net PPE: 490363000.00
PAMT cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 16990000.00
PAMT cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 0.00
PAMT balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 210426000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 73686000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 73686000.00
PAMT income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 8624000.00
PAMT income_statement (quarterly, 2026-03-31) — Normalized Income: -11624982.00
PAMT cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -2689000.00
PAMT cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -19077000.00
PAMT income_statement (quarterly, 2026-03-31) — Operating Income: -15417000.00
PAMT income_statement (quarterly, 2026-03-31) — Operating Revenue: 141880000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 20943237.00
PAMT income_statement (quarterly, 2026-03-31) — Other Income Expense: 19943000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 9671000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 5857000.00
PAMT income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 4797000.00
PAMT income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 6613000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Other Properties: 664908000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Other Receivables: 7113000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 40756000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Payables: 27981000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 70405000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
PAMT balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 8591000.00
PAMT income_statement (quarterly, 2026-03-31) — Pretax Income: -10000.00
PAMT cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
PAMT cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -14399000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Receivables: 88558000.00
PAMT income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 145476000.00
PAMT income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 19244000.00
PAMT income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 56604000.00
PAMT cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -165645000.00
PAMT cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -11000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 197494000.00
PAMT cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 11663000.00
PAMT cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 31389000.00
PAMT income_statement (quarterly, 2026-03-31) — Selling General And Administration: 5208000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Share Issued: 22395994.00
PAMT cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 144983000.00
PAMT cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -144983000.00
PAMT income_statement (quarterly, 2026-03-31) — Special Income Charges: 15146000.00
PAMT cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 98000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 210426000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 210426000.00
PAMT income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 3529018.00
PAMT income_statement (quarterly, 2026-03-31) — Tax Provision: -2000.00
PAMT income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.23
PAMT balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 1643000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Total Assets: 681025000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 462402000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Total Debt: 320651000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 210426000.00
PAMT income_statement (quarterly, 2026-03-31) — Total Expenses: 157297000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 470599000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 500034000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 331519000.00
PAMT income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -271000.00
PAMT income_statement (quarterly, 2026-03-31) — Total Unusual Items: 15146000.00
PAMT income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 15146000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 1452757.00
PAMT balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 28935000.00
PAMT balance_sheet (quarterly, 2026-03-31) — Working Capital: 41911000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — +Operating Expense: 3933700000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — +Total Revenue: 6592230000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 2347220000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 816560000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -6117270000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 1941740000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -39030000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Amortization: 7600000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 7600000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 399950000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 835900000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 61250746.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Basic EPS: 176.05
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 520790000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 3332920000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -125100000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 61250000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 503500000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 5516280000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 0.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 503500000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Change In Inventory: -385800000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -345600000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: 3008630000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Changes In Cash: -17290000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Common Stock: 61250000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 8766360000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 70790000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 3176680000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Current Assets: 9905500000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Current Debt: 520000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 520000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 850000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 7763670000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 123800000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Depreciation: 430170000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 437770000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 437770000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 430170000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 61250746.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Diluted EPS: 176.05
PANACEABIO.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 10783150000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — EBIT: 16291930000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — EBITDA: 16729700000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: -130000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — End Cash Position: 503500000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 700000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: -11758540000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 854480000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: -1209580000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -10000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of Business: -16762100000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -70000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 276710000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 138240000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 855590000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 12393990000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Gross Profit: 3415550000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 15750000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Interest Expense: 1798370000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 1798370000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Interest Income: 33940000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 33940000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -3897860000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 32800000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Inventory: 2127230000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 9107910000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: 12825730000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Investment Properties: 0.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 836600000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 2960000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 2478280000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 341030000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 341030000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 2960000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -7863640000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 291560000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 6512000000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Minority Interest: -29810000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Minority Interests: -190000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 18220000000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: 23920000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Net Income: 10783150000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 10783150000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 10783340000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Net Income Discontinuous Operations: 0.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 10783150000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 10783150000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 14493560000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 10783340000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Net Interest Income: -1774450000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: -5321970000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -7860680000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -7860680000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -1774450000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Net PPE: 6276720000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -105100000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 0.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 8628120000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Non Current Accrued Expenses: 0.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 455880000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 237510000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 0.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 194120000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: -16690000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Normalized Income: -1676315938.15
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: -1084480000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Operating Income: -518150000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Operating Revenue: 6592230000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 61250746.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: 130000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 613100000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 3204040000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 216540000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 138240000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: -15004690000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 147400000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 705900000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 33970000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 879790000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Other Payable: 45140000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Other Properties: 5878100000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 24980000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 5012780000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Other Special Charges: -16762130000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Payables: 2392360000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 359490000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 630600000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Pretax Income: 14493560000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: -22340000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: -10493600000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -125100000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 963810000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 3176680000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 437770000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 33970000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 33970000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -7863640000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 389900000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 8246270000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Sale Of Business: 18220000000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 5171630000.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 20000000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 480840000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 757550000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Share Issued: 61250746.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Short Term Debt Issuance: 0.00
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Short Term Debt Payments: 0.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Special Income Charges: 16746380000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 8766360000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 8628120000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 4286924061.85
PANACEABIO.NS income_statement (annual, 2022-03-31) — Tax Provision: 3710220000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.26
PANACEABIO.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -4037000000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Total Assets: 17588690000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 9107390000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Total Debt: 341550000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 8736550000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Total Expenses: 7110380000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 8852140000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 7683190000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 1088470000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 10020000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 900000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Total Unusual Items: 16746390000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 16746390000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Work In Process: 308940000.00
PANACEABIO.NS balance_sheet (annual, 2022-03-31) — Working Capital: 2141830000.00
PANACEABIO.NS income_statement (annual, 2022-03-31) — Write Off: 0.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — +Operating Expense: 2838150000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — +Total Revenue: 4569190000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 1773230000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 600920000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -6468910000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 1941740000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -40940000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Amortization: 2750000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 2750000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 60000000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 36640000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 61250746.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Basic EPS: -5.43
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 503500000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 3332920000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -409460000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 61250000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 398520000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 2130490000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 36220000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 362300000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 106300000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -238960000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -3369110000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -104940000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Common Stock: 61250000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 8436030000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 350100000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 2787580000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Current Assets: 5683200000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Current Debt: 550000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 550000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 5600000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 3318310000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Depreciation: 388480000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 391230000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 391230000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 388480000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 61250746.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Diluted EPS: -5.43
PANACEABIO.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -332370000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 5010000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — EBIT: 166080000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — EBITDA: 557310000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: -40000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — End Cash Position: 398520000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 700000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -183730000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 658310000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -4633980000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -19480000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of Business: -1026600000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -22990000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 158400000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 259410000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 641860000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 12702290000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Gross Profit: 1781610000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 29940000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Interest Expense: 38030000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 38030000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Interest Income: 115610000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 115610000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -35990000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 115610000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Inventory: 2020930000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 8638220000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 4303310000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 0.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 37340000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 0.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 2510020000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 201640000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 201640000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 0.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -147740000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 265470000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 6509250000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Minority Interest: -34890000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Minority Interests: 5080000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 35290000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Net Income: -332370000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -332370000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -337450000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -332370000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -332370000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 128050000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -337450000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Net Interest Income: 71240000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 4197100000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -147740000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -147740000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 71240000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Net PPE: 6233380000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -14410000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 0.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 8176620000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 321390000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 203710000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 435240000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: -496830000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Normalized Income: -1070268000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -4224520000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Operating Income: -1056540000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Operating Revenue: 4569190000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 61250746.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 566500000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 72060000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 216540000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 259410000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -1092200000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 493000000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 321400000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 33430000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 584280000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Other Payable: 10000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Other Properties: 5883300000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 27820000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 1731970000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Other Special Charges: -1073890000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Payables: 1773240000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 361420000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 559540000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Pretax Income: 128050000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -254820000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -8680700000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -409460000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 1201210000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 2787580000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 391230000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 34420000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 34420000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -147740000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 283500000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 7898520000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Sale Of Business: 0.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 12877800000.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 395050000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 427050000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 585450000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Share Issued: 61250746.00
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 0.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Special Income Charges: 1039670000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 8436030000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 8176620000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 316242000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Tax Provision: 465500000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.30
PANACEABIO.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -24770000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Total Assets: 12711660000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 8637670000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Total Debt: 202190000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 8401140000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Total Expenses: 5625730000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 4310520000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 7028460000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 992210000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 6340000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 5600000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 1054140000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 1054140000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Work In Process: 161410000.00
PANACEABIO.NS balance_sheet (annual, 2023-03-31) — Working Capital: 2364890000.00
PANACEABIO.NS income_statement (annual, 2023-03-31) — Write Off: 4280000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — +Operating Expense: 3271990000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — +Total Revenue: 5519290000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1455620000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 574190000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -6562160000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 1941740000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -42550000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Amortization: 23510000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 23510000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 0.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 8970000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 61250746.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Basic EPS: -0.19
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 398520000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 3196190000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -828760000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 61250000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 471740000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 1738370000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 65010000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 406730000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 241580000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -244640000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 102320000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 73190000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Common Stock: 61250000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 8420460000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 762910000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 2689520000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Current Assets: 4854670000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Current Debt: 0.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 0.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 1350000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 3089820000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 356900000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Depreciation: 343600000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 367110000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 367110000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 343600000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 61250746.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Diluted EPS: -0.19
PANACEABIO.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -11730000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 80000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — EBIT: 41500000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — EBITDA: 408610000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 30000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — End Cash Position: 471740000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 700000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -28080000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 466330000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -794080000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -33750000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 45590000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 295260000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 359980000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 616740000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 12925470000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Gross Profit: 2829770000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 46140000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Interest Expense: 26730000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 26730000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Interest Income: 83990000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 83990000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -25720000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 83730000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Inventory: 1779350000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 8570460000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: 66590000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 125940000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 9670000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 0.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 2524820000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 150000000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 150000000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 0.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -2360000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 277960000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 6441550000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Minority Interest: -38210000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Minority Interests: 3320000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 1260000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Net Income: -11730000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -11730000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -15050000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -11730000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -11730000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 14770000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -15050000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Net Interest Income: 48180000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 728820000.00